Insidertrades

Neurocrine Biosciences

NBIX

Neurocrine Biosciences is a publicly traded biopharmaceutical company founded in 1992. The company is headquartered in San Diego, California, and led by CEO Kevin Gorman. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbena …

© Wikipedia / Creative Commons CC-BY-SA 3.0 more at Wikipedia

Insider trades and stock quote 2024-2026

All insider trades at Neurocrine Biosciences

Subscribe RSS
Date Type Insider Position Ø-Price Volume
7/28/2026 Sell Norwalk, Leslie V. Director $182.0 $227,508
7/10/2026 Sell Delaet, Ingrid Chief Regulatory Officer $181.0 $790,514
7/9/2026 Sell Lippoldt, Darin Chief Legal Officer $179.6 $1,796,014
7/9/2026 Sell Delaet, Ingrid Chief Regulatory Officer $178.7 $1,507,135
7/8/2026 Sell Delaet, Ingrid Chief Regulatory Officer $178.5 $488,672
7/7/2026 Sell Delaet, Ingrid Chief Regulatory Officer $178.6 $607,305
6/29/2026 Sell Lippoldt, Darin Chief Legal Officer $170.4 $1,667,579
6/26/2026 Sell Lippoldt, Darin Chief Legal Officer $169.6 $33,913
6/5/2026 Sell Sherwin, Stephen A. Director $165.6 $4,132,969
6/4/2026 Sell Norwalk, Leslie V. Director $168.1 $210,072
6/2/2026 Sell Cooke, Julie Chief Human Resources Officer $156.6 $5,770,235
6/1/2026 Sell Onyia, Jude Chief Scientific Officer $160.2 $1,762,710
5/29/2026 Sell Delaet, Ingrid Chief Regulatory Officer $156.7 $354,321
5/27/2026 Sell Onyia, Jude Chief Scientific Officer $155.5 $1,710,865
5/26/2026 Sell Boyer, David W. Chief Corp. Affairs Officer $156.6 $609,023
5/19/2026 Sell Gorman, Kevin Charles Director $154.3 $37,824,872
5/15/2026 Sell Pops, Richard F. Director $157.7 $2,364,761
5/12/2026 Sell Norwalk, Leslie V. Director $155.0 $590,601
1/16/2026 Sell Gano, Kyle Chief Executive Officer $132.7 $4,830,458
12/16/2025 Sell Norwalk, Leslie V. Director $155.1 $184,558
12/15/2025 Sell Norwalk, Leslie V. Director $152.2 $761,144
12/8/2025 Sell Lippoldt, Darin Chief Legal Officer $159.6 $698,615
12/3/2025 Sell Lyons, Gary A. Director $152.6 $2,289,083
11/28/2025 Sell Benevich, Eric Chief Commercial Officer $151.7 $905,881
11/25/2025 Sell Morrow, George J. Director $143.4 $2,150,513
11/5/2025 Sell Rastetter, William H. Director $151.8 $2,732,690
11/4/2025 Sell Gano, Kyle Chief Executive Officer $142.0 $42,591
8/7/2025 Sell Gorman, Kevin Charles Director $126.4 $13,440,281
7/10/2025 Sell Delaet, Ingrid Chief Regulatory Officer $135.0 $61,695
7/9/2025 Sell Onyia, Jude Chief Scientific Officer $130.5 $7,803,688
7/2/2025 Sell Onyia, Jude Chief Scientific Officer $130.1 $2,649,738
5/27/2025 Sell Gorman, Kevin Charles Director $120.4 $1,157,211
5/5/2025 Sell Rastetter, William H. Director $110.2 $3,305,952
2/14/2025 Sell Roberts, Eiry Chief Medical Officer $115.0 $57,521
2/13/2025 Sell Abernethy, Matt Chief Financial Officer $116.9 $298,923
2/13/2025 Sell Benevich, Eric Chief Commercial Officer $116.7 $251,428
2/13/2025 Sell Boyer, David W. Chief Corp. Affairs Officer $116.7 $208,387
2/13/2025 Sell Delaet, Ingrid Chief Regulatory Officer $116.7 $171,674
2/13/2025 Sell Gano, Kyle Chief Executive Officer $116.8 $298,908
2/13/2025 Sell Lippoldt, Darin Chief Legal Officer $116.8 $254,992
2/13/2025 Sell Onyia, Jude Chief Scientific Officer $116.8 $336,239
2/13/2025 Sell Roberts, Eiry Chief Medical Officer $116.8 $200,742
2/13/2025 Sell Sherwin, Stephen A. Director $116.7 $1,613,923
2/13/2025 Sell Gorman, Kevin Charles Director $116.7 $681,915
2/13/2025 Sell Cooke, Julie Chief Human Resources Officer $116.8 $181,129
2/10/2025 Sell Abernethy, Matt Chief Financial Officer $118.3 $115,909
2/10/2025 Sell Benevich, Eric Chief Commercial Officer $118.3 $115,940
2/10/2025 Sell Boyer, David W. Chief Corp. Affairs Officer $118.3 $82,820
2/10/2025 Sell Gano, Kyle Chief Executive Officer $118.4 $116,020
2/10/2025 Sell Lippoldt, Darin Chief Legal Officer $118.3 $107,727
2/10/2025 Sell Roberts, Eiry Chief Medical Officer $118.2 $115,853
2/10/2025 Sell Gorman, Kevin Charles Director $118.4 $269,167
2/10/2025 Sell Cooke, Julie Chief Human Resources Officer $118.3 $82,793
2/3/2025 Sell Delaet, Ingrid Chief Regulatory Officer $149.3 $93,008
1/31/2025 Sell Abernethy, Matt Chief Financial Officer $152.9 $196,136
1/31/2025 Sell Benevich, Eric Chief Commercial Officer $152.9 $184,599
1/31/2025 Sell Boyer, David W. Chief Corp. Affairs Officer $152.9 $168,849
1/31/2025 Sell Delaet, Ingrid Chief Regulatory Officer $153.0 $64,587
1/31/2025 Sell Gano, Kyle Chief Executive Officer $152.9 $235,577
1/31/2025 Sell Lippoldt, Darin Chief Legal Officer $152.9 $191,133
1/31/2025 Sell Onyia, Jude Chief Scientific Officer $153.0 $19,274
1/31/2025 Sell Roberts, Eiry Chief Medical Officer $152.8 $222,636
1/31/2025 Sell Gorman, Kevin Charles Director $152.9 $413,967
1/31/2025 Sell Cooke, Julie Chief Human Resources Officer $152.9 $266,025
1/27/2025 Sell Gorman, Kevin Charles Director $149.5 $21,836,503
1/15/2025 Sell Gano, Kyle Chief Executive Officer $141.5 $9,197,550
12/31/2024 Sell Delaet, Ingrid Chief Regulatory Officer $138.1 $37,563
12/17/2024 Sell Delaet, Ingrid Chief Regulatory Officer $135.0 $147,285
11/29/2024 Sell Onyia, Jude Chief Scientific Officer $126.3 $294,373
10/3/2024 Sell Boyer, David W. Chief Corp. Affairs Officer $113.7 $147,190
9/13/2024 Sell Boyer, David W. Chief Corp. Affairs Officer $121.9 $421,828
8/15/2024 Sell Rastetter, William H. Director $146.7 $2,090,333
8/13/2024 Sell Delaet, Ingrid Chief Regulatory Officer $150.1 $1,072,180
8/13/2024 Sell Abernethy, Matt Chief Financial Officer $150.4 $2,120,347
8/13/2024 Sell Lyons, Gary A. Director $150.4 $1,740,450
Rows per page:
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)